| Literature DB >> 31672889 |
Markus Ruetz1, Gregory C Campanello1, Meredith Purchal2, Hongying Shen3,4, Liam McDevitt1, Harsha Gouda1, Shoko Wakabayashi5, Junhao Zhu5, Eric J Rubin5, Kurt Warncke6, Vamsi K Mootha3,4, Markos Koutmos2,7, Ruma Banerjee8.
Abstract
Itaconate is an immunometabolite with both anti-inflammatory and bactericidal effects. Its coenzyme A (CoA) derivative, itaconyl-CoA, inhibits B12-dependent methylmalonyl-CoA mutase (MCM) by an unknown mechanism. We demonstrate that itaconyl-CoA is a suicide inactivator of human and Mycobacterium tuberculosis MCM, which forms a markedly air-stable biradical adduct with the 5'-deoxyadenosyl moiety of the B12 coenzyme. Termination of the catalytic cycle in this way impairs communication between MCM and its auxiliary repair proteins. Crystallography and spectroscopy of the inhibited enzyme are consistent with a metal-centered cobalt radical ~6 angstroms away from the tertiary carbon-centered radical and suggest a means of controlling radical trajectories during MCM catalysis. Mycobacterial MCM thus joins enzymes in the glyoxylate shunt and the methylcitrate cycle as targets of itaconate in pathogen propionate metabolism.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31672889 PMCID: PMC7070230 DOI: 10.1126/science.aay0934
Source DB: PubMed Journal: Science ISSN: 0036-8075 Impact factor: 47.728